ReviewJournal of clinical medicine2020
Diagnostic and Therapeutic Management of Upper Extremity Deep Vein Thrombosis.
Review in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.
- The American Venous Forum clinical practice guideline on the care of patients with upper extremity deep venous thrombosis.Journal of vascular surgery. Venous and lymphatic disorders · 2026Guideline
- Comparative analysis of risk prediction scores including all types of cancer-associated thrombosis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Observational
- Article
- Article
- Late-onset transvenous pacemaker lead-associated thrombosis.The British journal of cardiology · 2026Article
- Predictive Value of Centered Clinical Asymmetric Lower Limb Edema in Diagnosing Deep Vein Thrombosis in Puerperium.Journal of clinical medicine · 2025Article
- Massive upper extremity deep venous thrombosis after a transvenous lead extraction successfully treated by an anti-thrombotic regimen.HeartRhythm case reports · 2025Article
- An unusual case of deep vein thrombosis of the upper extremity following breast reduction.Case reports in plastic surgery & hand surgery · 2025Article
- Subacute Paget-Schroetter with rapid recurrence and concurrent pulmonary emboli: a case report.Frontiers in surgery · 2025Article
- Spontaneous upper extremity deep vein thrombosis as initial manifestation of a malignant mediastinal teratoma.Archive of clinical cases · 2025Article
- A multi-center big-data approach for precise PICC-RVT prognosis and identification of major risk factors in clinical practice.Heliyon · 2024Article
- A 12-Year Review of Upper Extremity Deep Vein Thrombosis-Are They the Same as Lower Extremity Deep Vein Thrombosis?Journal of clinical medicine · 2024Article
- Upper Extremity Deep Vein Thrombosis: Incidence, Risk Factors, and Effectiveness of Chemoprophylaxis.Southern medical journal · 2024Article
- Short Course Antibiotic Therapy for Catheter-Related Septic Thrombosis: "Caveat Emptor!": Duration of Therapy Should Not Be SetPathogens (Basel, Switzerland) · 2024Review
- Article
- A Rare Cause of Deep Vein Thrombosis in a Young Orchestra Conductor.Diagnostics (Basel, Switzerland) · 2024Article
- Integrating deep learning in public health: a novel approach to PICC-RVT risk assessment.Frontiers in public health · 2024Article
- Efficacy and safety of rivaroxaban versus warfarin in the management of unusual site deep vein thrombosis: a retrospective cohort study.Frontiers in pharmacology · 2024Article
- Treating Deep Venous Thrombosis in a Background of Crohn's Disease: A Clinical Conundrum.Cureus · 2023Article
- Left brachiocephalic venous thrombus initially presenting as acute aortic syndrome.Journal of surgical case reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Upper extremity deep vein thrombosis (UEDVT) accounts for 5% of all deep vein thromboses (DVTs). UEDVT may be complicated by post thrombotic syndrome and pulmonary embolism, and early recognition and prompt start of anticoagulant treatment are key. Primary UEDVT, also known as Paget-von Schrötter syndrome, is associated with repeated or sudden physical activity of the upper arm and venous outflow obstruction due to anatomical variations. Secondary UEDVT is often associated with malignancy or use of intravenous devices, such as central venous catheters or pacemaker leads. Although the diagnosis and treatment of UEDVT have many similarities with DVT of the lower extremities, knowledge of specific aspects regarding UEDVT is important to guide optimal management. In this review, we will discuss the epidemiology, diagnosis, and treatment of UEDVT based on the current literature.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.